Senescence-induced alterations of laminin chain expression modulate tumorigenicity of prostate cancer cells

Neoplasia

Volumn 10, Issue 12, 2008, Pages 1350-1361

  Sprenger, Cynthia C T ^a,b   Drivdahl, Rolf H ^a,b   Woodke, Lillie B ^b,c   Eyman, Daniel ^b   Reed, May J ^b   Carter, William G ^d   Plymate, Stephen R ^b,c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ ALPHA4; LAMININ GAMMA1; MESSENGER RNA;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL AGING; CELL PROLIFERATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MICROENVIRONMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SENESCENCE;

EID: 57349188407     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.08746     Document Type: Article

References (53)

1. Hsing A, Tsao L, and Devesa S (2000). International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 85, 60-67.
2. Nelson W, De Marzo A, and Isaacs W (2003). Mechanisms of disease: prostate cancer. N Engl J Med 349, 366-381.
3. Soto A and Sonnenschein C (2004). The somatic mutation theory of cancer: growing problems with the paradigm? BioEssays 26, 1097-1107.
4. Bissell M and Radisky D (2001). Putting tumours in context. Nat Rev Cancer 1, 46-54.
5. Campisi J (2005). Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 120, 513-522.
6. Bavik C, Coleman I, Dean J, Knudsen B, Plymate S, and Nelson P (2006). The gene expression program of prostate fibroblast senescence modulates neoplastic epithelial cell proliferation through paracrine mechanisms. Cancer Res 66, 794-802.
7. Krtolica A and Campisi J (2002). Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol 34, 1401-1414.
8. Dimri G (2005). What has senescence got to do with cancer? Cancer Cell 7, 505-512.
9. Choi J, Shendrik I, Peacocke M, Peehl D, Buttyan R, Ikeguchi E, Katz A, and Benson M (2000). Expression of senescence-associated beta-galactosidase in enlarged prostates from men with benign prostatic hyperplasia. Urology 56, 160-166.
10. Jarrard D, Sarkar S, Shi Y, Yeager T, Magrane G, Kinoshita H, Nassif N, Meisner L, Newton M, Waldman F, et al. (1999). p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells. Cancer Res 59, 2957-2964.
11. Lopez Bermejo A, Buckway C, Devi G, Hwa V, Plymate S, Oh Y, and Rosenfeld R (2000). Characterization of insulin-like growth factor-binding protein-related proteins (IGFBP-rP1s) 1, 2, and 3 in human prostate epithelial cells: potential roles for IGFBP-rP1 and 2 in senescence of the prostatic epithelium. Endocrinology 141, 4072-4080.
12. Schwarze S, Shi Y, Fu V, Watson P, and Jarrard D (2001). Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cells. Oncogene 20, 8184-8192.
13. Untergasser G, Koch H, Menssen A, and Hermeking H (2002). Characterization of epithelial senescence by serial analysis of gene expression: identification of genes potentially involved in prostate cancer. Cancer Res 62, 6255-6262.
14. Castro P, Xia C, Gomez L, Lamb D, and Ittmann M (2004). Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60, 153-159.
15. Castro P, Giri D, Lamb D, and Ittmann M (2003). Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate 55, 30-38.
16. Chang B-D, Broude E, Dokmanovic M, Zhu H, Ruth A, Xuan Y, Kandel E, Lausch E, Christov K, and Roninson I (1999). A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res 59, 3761-3767.
17. Hwang E (2002). Replicative senescence and senescence-like state induced in cancer-derived cells. Mech Ageing Dev 123, 1681-1694.
18. Schwarze S, Fu V, Desotelle J, Kenowski M, and Jarrard D (2005). The identification of senescence-specific genes during the induction of senescence in prostate cancer cells. Neoplasia 7, 816-823.
19. Sprenger C, Damon S, Hwa V, Rosenfeld R, and Plymate S (1999). Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res 59, 2370-2375.
20. 1 and cyclin A associated apoptosis. Oncogene 21, 140-147.
21. Plymate S, Haugk K, Sprenger C, Nelson P, Tennant M, Zhang Y, Oberley L, Zhong W, Drivdahl R, and Oberley T (2003). Increased manganese superoxide dismutase (SOD-2) is part of the mechanism for prostate tumor suppression by mac25/insulin-like growth factor binding-protein-related protein-1. Oncogene 22, 1024-1034.
22. Patarroyo M, Tryggvason K, and Virtanen I (2002). Laminin isoforms in tumor invasion, angiogenesis and metastasis. Semin Cancer Biol 12, 197-207.
23. Givant-Horwitz V, Davidson B, and Reich R (2005). Laminin-induced signaling in tumor cells. Cancer Lett 223, 1-10.
24. Fujita M, Khazenzon N, Bose S, Sekiguchi K, Sasaki T, Carter W, Ljubimov A, Black K, and Ljubimova J (2005). Overexpression of β1-chain-containing laminins in capillary basement membranes of human breast cancer and its metastases. Breast Cancer Res 7, R411-R421.
25. Ljubimova J, Fugita M, Khazenzon N, Das A, Pikul B, Newman D, Sorokin L, Sasaki T, and Black K (2004). Association between laminin-8 and glial tumor grade, recurrence, and patient survival. Cancer 101, 604-612.
26. Nagle R (2004). Role of the extracellular matrix in prostate carcinogenesis. J Cell Biochem 91, 36-40.
27. Bae V, Jackson-Cook C, Maygarden S, Plymate S, Chen J, and Ware J (1998). Metastatic sublines of an SV40 large T antigen immortalized human prostate epithelial cell line. Prostate 34, 275-282.
28. Hao J, Yang Y, McDaniel K, Dalkin B, Cress A, and Nagle R (1996). Differential expression of laminin 5 (α3β3γ2) by human malignant and normal prostate. Am J Pathol 149, 1341-1349.
29. Zhang H, Pan K-H, and Cohen S (2003). Senescence-specific gene expression fingerprints reveal cell-type-dependent physical clustering of up-regulated chromosomal loci. Proc Natl Acad Sci USA 100, 3251-3256.
30. Drivdahl R, Haugk K, Sprenger C, Nelson P, Tennant M, and Plymate S (2004). Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9. Oncogene 23, 4584-4593.
31. Sigle R, Gil S, Bhattacharya M, Ryan M, Yang T-M, Brown T, Boutaud A, Miyashita Y, Olerud J, and Carter W (2004). Globular domains 4/5 of the laminin α3 chain mediate deposition of precursor laminin 5. J Cell Sci 177, 4481-4494.
32. Labat-Robert J (2002). Fibronectin in malignancy - effect of aging. Semin Cancer Biol 12, 187-195.
33. Kumazaki T, Wadhwa R, Kual S, and Mitsui Y (1997). Expression of endothelin, fibronectin, and mortalin as aging and mortality markers. Exp Gerentol 32, 95-103.
34. Kaspar M, Zardi L, and Neri D (2006). Fibronectin as target for tumor therapy. Int J Cancer 118, 1331-1339.
35. Brar P, Dalkin B, Weyer C, Sallam K, Virtanen I, and Nagle R (2003). Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubertal benign prostate glands and adult benign and malignant prostate glands. Prostate 55, 65-70.
36. Frank D and Carter W (2004). Laminin 5 deposition regulates keratinocyte polarization and persistent migration. J Cell Sci 117, 1351-1363.
37. Ryan M, Lee K, Miyashita Y, and Carter W (1999). Targeted disruption of the LAMA3 gene in mice reveals abnormalities in survival and late stage differentiation of epithelial cells. J Cell Biol 145, 1309-1323.
38. 4 integrins in human prostate cancer progression. Cancer Metastasis Rev 14, 219-228.
39. Sathyanarayana U, Padar A, Suzuki M, Maruyama R, Shigematsu H, Hsieh J-T, Frenkel E, and Gazdar A (2003). Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. Clin Cancer Res 9, 6395-6400.
40. Calaluce R, Bearss D, Barrera J, Zhao Y, Han H, Beck S, McDaniel K, and Nagle R (2004). Laminin-5 beta3A expression in LNCaP human prostate carcinoma cells increases cell migration and tumorigenicity. Neoplasia 6, 468-479.
41. Luo J, Dunn T, Ewing C, Sauvageot J, Chen Y, Trent J, and Isaacs W (2002). Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. Prostate 51, 189-200.
42. 4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Cancer Res 61, 5601-5610.
43. Khazenzon N, Ljubimov A, Lakhter A, Fujita M, Fujiwara H, Sekiguchi K, Sorokin L, Petajaniemi N, Virtanen I, Black K, et al. (2003). Antisense inhibition of laminin-8 expression reduces invasion of human gliomas in vitro. Mol Cancer Ther 2, 986-994.
44. Chung L, Baseman A, Assikis V, and Zhau H (2005). Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. J Urol 173, 10-20.
45. Bissell M (1999). Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. Am J Pathol 155, 675-679.
46. Udayakumar T, Chen M, Bair E, von Bredow D, Cress A, Nagle R, and Bowden G (2003). Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 β3 chain and induces cell migration. Cancer Res 63, 2292-2299.
47. Yu H-M, Frank D, Zhang J, You X, Carter W, and Knudsen B (2004). Basal prostate epithelial cells stimulate the migration of prostate cancer cells. Mol Carcinog 41, 85-97.
48. Pfohler C, Fixemer T, Jung V, Dooley S, Remberger K, and Bonkhoff H (1998). In situ hybridization analysis of genes coding collagen IV α1 chain, laminin β1 chain, and S-laminin in prostate tissue and prostate cancer: increased basement membrane gene expression in high-grade and metastatic lesions. Prostate 36, 143-150.
49. Fujita M, Khazenzon N, Ljubimov A, Lee B-S, Virtanen I, Holler E, Black K, and Ljubimova J (2006). Inhibition of laminin-8 in vivo using a novel poly(malic acid)-based carrier reduces glioma angiogenesis. Angiogenesis 9, 183-191.
50. Wewer U, Gerecke D, Durkin M, Kurtz K, Mattei M-G, Champliaud M, Burgeson R, and Albrechtsen R (1994). Human β2 chain of laminin (formerly S chain): cDNA cloning, chromosomal localization, and expression in carcinomas. Genomics 24, 243-252.
51. Ricciardelli C and Rodgers R (2006). Extracellular matrix of ovarian tumors. Semin Reprod Med 24, 270-282.
52. Bao Y, Yoshida D, Morimoto D, and Teramoto A (2006). Expression of laminin beta2: a novel marker of hypoxia in pituitary adenomas. Endocr Pathol 17, 251-261.
53. Champliaud M, Lunstrum G, Rousselle P, Nishiyama T, Keene D, and Burgeson R (1996). Human amnion contains a novel laminin variant, laminin 7, which like laminin 6, covalently associates with laminin 5 to promote stable epithelial-stromal attachment. J Cell Biol 132, 1189-1198.